Search results

Jump to navigation Jump to search
  • ...tor that binds to an enzyme at a site other than the [[active site]]. This binding changes the conformation of the enzyme, enhancing its activity and increasi ...at these activators bind to a different site on the enzyme, not the active site.
    2 KB (216 words) - 04:00, 11 February 2024
  • ...ng in an apparent change in binding affinity at a different ligand binding site. ...sites, and binding at one site can affect the enzyme's activity at another site.
    2 KB (289 words) - 23:01, 9 February 2024
  • ...binding of an effector molecule at a site other than the protein's active site. ...tein when an effector molecule binds to it at a site other than the active site.
    1 KB (221 words) - 05:40, 11 February 2024
  • ...hibitor]] that does not compete with the substrate for the enzyme's active site. ...inhibitor that does not compete with the substrate for the enzyme's active site.
    2 KB (225 words) - 22:34, 7 February 2024
  • == Allosteric Site == ...]] or [[protein]] where a molecule other than the substrate can bind. This binding can influence the protein's function and is a key concept in [[biochemistry
    1 KB (189 words) - 03:40, 9 February 2024
  • == Binding (medicine) == '''Binding''' (pronounced: /ˈbaɪndɪŋ/), in the context of medicine, refers to the
    2 KB (246 words) - 23:31, 4 February 2024
  • ...r]] competes with the [[substrate]] for binding to the [[enzyme]]'s active site. The term originates from the Latin words 'competere' meaning 'strive in co ...f inhibition is reversible as the inhibitor can be removed from the active site, allowing the substrate to bind again.
    2 KB (250 words) - 06:47, 11 February 2024
  • ...ds to the same active site as the substrate, preventing the substrate from binding. ...enzyme, changing the shape of the enzyme and preventing the substrate from binding effectively.
    2 KB (207 words) - 11:51, 10 February 2024
  • ...the Latin word 'ligandum', meaning 'that which binds', in reference to the binding action of the ligand. ...mational isomerism (conformation) of the target protein. In [[DNA]]-ligand binding studies, the ligand can be a small molecule, ion, or protein which binds to
    2 KB (273 words) - 21:58, 14 February 2024
  • ...the binding of an [[Effector molecule]] at a site other than the [[Active site]]. ...property of certain systems in which the shape of the system changes upon binding of one ligand, which alters the affinity of the remaining sites for ligand.
    2 KB (226 words) - 05:53, 14 February 2024
  • ...or receptor, either by increasing the binding affinity of the orthosteric site for its [[Ligand (biochemistry)|ligand]], or by increasing the efficacy of * [[Allosteric Site]]
    2 KB (217 words) - 21:23, 14 February 2024
  • ...at one site on a protein can have on the protein's function at a different site. ...ility to bind to the substrate. This location is known as the [[allosteric site]].
    2 KB (291 words) - 01:34, 13 February 2024
  • ...otein at a site different from the active site of the primary ligand. This binding causes a conformational change in the protein, which can either enhance or * [[Allosteric site]]: The site on a protein where an allosteric modulator binds.
    2 KB (219 words) - 04:01, 11 February 2024
  • ...rt of the enzyme, causing the enzyme to change shape and making the active site less effective at catalyzing the reaction. ...the inhibitor does not compete with the substrate for the enzyme's active site. The prefix "non-" means "not," "competitive" refers to competition, and "i
    1 KB (209 words) - 14:52, 11 February 2024
  • ...gy]] is a type of [[Drug]] that blocks or dampens a biological response by binding to and blocking a [[Receptor]] rather than activating it like an [[Agonist] ...e on the receptor. If the antagonist binds, it will block the agonist from binding and prevent its action.
    2 KB (229 words) - 23:31, 14 February 2024
  • ...that binds to the active site of an enzyme, preventing the substrate from binding and thus inhibiting the reaction. ...e site, changing the shape of the enzyme and preventing the substrate from binding.
    2 KB (238 words) - 20:06, 5 February 2024
  • ...the active site of a receptor without activating it, thereby blocking the binding of endogenous ligands or [[Agonist|agonists]]. This prevents the receptor f ...agonist, but do not activate the receptor. They compete with agonists for binding, and their effects can be overcome by increasing the concentration of the a
    2 KB (259 words) - 03:54, 11 February 2024
  • ...]]: A substance that binds to the active site of an enzyme, preventing the binding of the substrate and thus inhibiting the enzyme's function. ...e site, changing the shape of the enzyme and preventing the substrate from binding.
    2 KB (218 words) - 06:55, 13 February 2024
  • ...inhibitor]] that binds to the [[active site]] of an enzyme, preventing the binding of the [[substrate]] and thus inhibiting the enzyme's function. ...the inhibitor's ability to compete with the substrate for the same active site on the enzyme. The term 'inhibitor' is derived from the Latin word 'inhibit
    1 KB (215 words) - 05:48, 11 February 2024
  • ...ntext of immunology and biochemistry, it refers to the overall strength of binding between a molecule and its receptor or ligand. ...stry)|Affinity]]: The strength of the interaction between a single binding site of a molecule and its ligand or receptor.
    1 KB (167 words) - 23:26, 4 February 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)